Abbott Laboratories (ABT)
-NYSE 36.59 
0.24(0.65%) May 17, 4:04PM EDT|After Hours
:
36.59 0.00 (0.00%) May 17, 7:24PM EDT
| Prev Close: | 36.83 |
|---|
| Open: | 36.82 |
|---|
| Bid: | 36.13 x 200 |
|---|
| Ask: | 37.62 x 100 |
|---|
| 1y Target Est: | 39.94 |
|---|
| Beta: | 0.53 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 36.29 - 36.94 |
|---|
| 52wk Range: | 28.46 - 37.70 |
|---|
| Volume: | 7,050,721 |
|---|
| Avg Vol (3m): | 7,331,870 |
|---|
| Market Cap: | 57.04B |
|---|
| P/E (ttm): | 11.15 |
|---|
| EPS (ttm): | 3.28 |
|---|
| Div & Yield: | 0.56 (1.50%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Abbott Laboratories Stock Checkup for Mayat Motley Fool(Fri, May 17)
- Jim Cramer's Down and Out Turnaround Playat CNBC(Fri, May 17)
- [video] Companies That Shine After Spinoffsat CNBC(Fri, May 17)
- Cramer: Break-Up Could Boost This Stock 19%at CNBC(Fri, May 17)
- [$$] AbbVie Is Good Medicineat Barrons.com(Thu, May 16)
- Here's What This Big Market-Beater Has Been Buying and Sellingat Motley Fool(Thu, May 16)
- Google’s Page Describes Speech Malady, Funds Researchat Bloomberg(Wed, May 15)
- J&J Wins Expanded Approval of Simponi for Bowel Diseaseat Bloomberg(Wed, May 15)
- LabStyle Innovations - Glucose Monitoring For The Mobile Ageat Seeking Alpha(Wed, May 15)
- Three Stocks that Offer Protection from Market Tantrumsat Motley Fool(Wed, May 15)
- 3 Pharmaceuticals For Attractive Dividendsat Seeking Alpha(Wed, May 15)
- Zacks Analyst Say 'Buy' LabStyle InnovationsZacks Small Cap Research(Wed, May 15)
- Abbott Laboratories (ABT): Today's Featured Health Services Winnerat TheStreet(Tue, May 14)
- ABBOTT LABORATORIES FinancialsEDGAR Online Financials(Tue, May 14)
- Cramer Says Buy Abbott Labs, Cedar Fair, and These 2 Stocksat Wall St. Cheat Sheet(Tue, May 14)
Key Statistics
| Forward P/E (1 yr): | 16.26 |
|---|
| P/S (ttm): | 1.44 |
|---|
| Ex-Dividend Date: | 11-Apr-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 2.01 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.44 |
|---|
| Mean Recommendation*: | 2.6 |
|---|
| PEG Ratio (5 yr expected): | 1.49 |
|---|
Business Summary
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine ins...
View More